Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
generalStage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.)
62
Centers
126
Active Trials
—
Cancer Funding
Top Centers for Clinical Stage IV Esophageal Adenocarcinoma AJCC v8(62)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | University of Illinois Cancer CenterChicago, IL High-Volume Research Center | 72.9 |
| 2 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive High-Volume Research Center | 70.4 |
| 3 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive High-Volume Research Center | 70.4 |
| 4 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive High-Volume Research Center | 70.4 |
| 5 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical High-Volume Research Center | 70.4 |
| 6 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR High-Volume Research Center | 70.4 |
| 7 | Cancer Center at IllinoisUrbana, IL High-Volume Research Center | 70.4 |
| 8 | NCI Comprehensive Active Research Program | 64.6 |
| 9 | NCI Comprehensive Active Research Program | 64.6 |
| 10 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 64.6 |
| 11 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 64.6 |
| 12 | NCI Clinical Active Research Program | 64.6 |
| 13 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 64.6 |
| 14 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program | 64.6 |
| 15 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 64.6 |
| 16 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 64.6 |
| 17 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 64.6 |
| 18 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 53.0 |
| 19 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 53.0 |
| 20 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 53.0 |
| 21 | NCI Comprehensive Active Research Program | 53.0 |
| 22 | NCI Comprehensive Active Research Program | 53.0 |
| 23 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program | 53.0 |
| 24 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 53.0 |
| 25 | NCI Comprehensive Active Research Program | 53.0 |
| 26 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 53.0 |
| 27 | NCI Comprehensive Active Research Program | 53.0 |
| 28 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 53.0 |
| 29 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 53.0 |
| 30 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program | 53.0 |
| 31 | Georgetown Lombardi Comprehensive Cancer CenterWashington, DC NCI Comprehensive Active Research Program | 53.0 |
| 32 | Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive Active Research Program | 53.0 |
| 33 | University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical Active Research Program | 53.0 |
| 34 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program | 53.0 |
| 35 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 53.0 |
| 36 | The University of Vermont Cancer CenterBurlington, VT Active Research Program | 53.0 |
| 37 | Active Research Program | 53.0 |
| 38 | Northwell Health Cancer InstituteNew York, NY Active Research Program | 53.0 |
| 39 | University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program | 53.0 |
| 40 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 36.7 |
| 41 | NCI Comprehensive Active Research Program | 36.7 |
| 42 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 36.7 |
| 43 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 36.7 |
| 44 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program | 36.7 |
| 45 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program | 36.7 |
| 46 | NCI Comprehensive Active Research Program | 36.7 |
| 47 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 36.7 |
| 48 | NCI Comprehensive Active Research Program | 36.7 |
| 49 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 36.7 |
| 50 | UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program | 36.7 |
| 51 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 36.7 |
| 52 | Cedars-Sinai CancerLos Angeles, CA Active Research Program | 36.7 |
| 53 | Wilmot Cancer Institute, UR MedicineRochester, NY NCI Clinical Active Research Program | 36.7 |
| 54 | Atrium Health Wake Forest Baptist Comprehensive Cancer CenterWinston-Salem, NC NCI Comprehensive Active Research Program | 36.7 |
| 55 | Boston University Cancer CenterBoston, MA Active Research Program | 36.7 |
| 56 | Active Research Program | 36.7 |
| 57 | Stony Brook Cancer CenterStony Brook, NY Active Research Program | 36.7 |
| 58 | Penn State Cancer InstituteHershey, PA Active Research Program | 36.7 |
| 59 | UofL James Graham Brown Cancer CenterLouisville, KY Active Research Program | 36.7 |
| 60 | Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program | 36.7 |
| 61 | Loma Linda University Cancer CenterLoma Linda, CA Active Research Program | 36.7 |
| 62 | Active Research Program | 36.7 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →